- Home
- / AXIM Biotechnologies
AXIM Biotechnologies
Stock Price
$0
2024-10-29
Market Capitalization
$1.5 M
2024-10-29
Revenue
$39.5 K
FY, 2023
AXIM Biotechnologies Summary
Company Summary
- Overview
- AXIM Biotechnologies is a biotechnology company working on the treatment of pain, spasticity, anxiety, and other medical disorders. It focuses on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- New York, NY, US | view all locations
- Website
- http://aximbiotech.com/
- Cybersecurity rating
Table of Contents
Key People
George E. Anastassov, Founder, Chairman of the Board
Lekhram Changoer, Chief Technology Officer, Director
Philip A. Van Damme, Chief Medical Officer, Board Member
Operating MetricsView all
Patent Applications
13
8.3%
Q3, 2019
Patents Licensed
2
100.0%
Q3, 2019
Trademark Applications
28
3.7%
Q3, 2019
LocationsView all
2 locations detected
New York, NY HQ
United States
45 Rockefeller Plaza 20th fl
San Diego, CA
United States
6191 Cornerstone Ct E #114
AXIM Biotechnologies Financials
Summary Financials
- Revenue (Q2, 2024)
- $17.5K
- Gross profit (Q2, 2024)
- $15.7K
- Net income (Q2, 2024)
- ($2.3M)
- Cash (Q2, 2024)
- $6.0K
- EBIT (Q2, 2024)
- ($569.4K)
- Enterprise value
- $8.3M